Annual Report

Overview

The report presents Yuhan Corporation's 2020 consolidated sales of KRW 1,619,865,302,675 and highlights strong operating performance. It also details the conditional approval and planned launch of the LECLAZA lung-cancer treatment. ESG disclosures include Scope 1 and Scope 2 greenhouse-gas emissions, water and industrial-waste data, and environmental management activities. The report further describes ISO 14001, ISO 45001, and ISO 37001 certifications and related management systems.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Financial
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: English
Pages
File size

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services